Horling; Franziska

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horling; Franziska.The latest application filed is for "viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a".

Company Profile

6.6.10

Horling; Franziska - Gaenserndorf AT
Horling; Franziska - Ganserndorf AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20220213172 - Falkner; Falko-Gunter ; et al.	2022-07-07
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 11,254,731 - Falkner , et al. February 22, 2	2022-02-22
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B App 20210128700 - Horling; Franziska ; et al.	2021-05-06
Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B Grant 10,842,853 - Horling , et al. November 24, 2	2020-11-24
Gene Therapy Of Hemophilia B Using Viral Vectors Encoding Recombinant Fix Variants With Increased Expression App 20200246437 - Kind Code	2020-08-06
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20190202893 - Falkner; Falko-Gunter ; et al.	2019-07-04
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20190194295 - Falkner; Falko-Gunter ; et al.	2019-06-27
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 10,189,889 - Falkner , et al. Ja	2019-01-29
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 10,189,888 - Falkner , et al. Ja	2019-01-29
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B App 20180339026 - Horling; Franziska ; et al.	2018-11-29
Factor X activation Grant 10,036,002 - Hasslacher , et al. July 31, 2	2018-07-31
Production of fully processed and functional factor X in a furin-secreting mammalian expression system Grant 9,873,892 - Bohm , et al. January 23, 2	2018-01-23
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20170233455 - Falkner; Falko-Gunter ; et al.	2017-08-17
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20170226188 - Falkner; Falko-Gunter ; et al.	2017-08-10
Factor X Activation App 20160046922 - Hasslacher; Meinhard ; et al.	2016-02-18
Production Of Fully Processed And Functional Factor X In A Furin-secreting Mammalian Expression System App 20160046957 - Bohm; Ernst ; et al.	2016-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.